Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent advances in oncoproteomics.

Kewal K Jain1

  • 1Jain PharmaBiotech, Basel, Switzerland. jain@pharmabiotech.ch

Current Opinion in Molecular Therapeutics
|July 26, 2002
PubMed
Summary
This summary is machine-generated.

Proteomics advances cancer research by identifying differentially expressed proteins using laser capture microdissection and SELDI technology. This aids in cancer diagnosis and the development of personalized cancer therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Personalized Immuno-Oncology.

Medical principles and practice : international journal of the Kuwait University, Health Science Centre·2020
Same author

An Overview of Drug Delivery Systems.

Methods in molecular biology (Clifton, N.J.)·2019
Same author

Role of Nanobiotechnology in Drug Delivery.

Methods in molecular biology (Clifton, N.J.)·2019
Same author

A Critical Overview of Targeted Therapies for Glioblastoma.

Frontiers in oncology·2018
Same author

Personalized neurology.

Personalized medicine·2018
Same author

Personalized Management of Cardiovascular Disorders.

Medical principles and practice : international journal of the Kuwait University, Health Science Centre·2017
Same journal

Gene therapy: Have the risks associated with viral vectors been solved?

Current opinion in molecular therapeutics·2011
Same journal

Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome.

Current opinion in molecular therapeutics·2010
Same journal

Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes.

Current opinion in molecular therapeutics·2010
Same journal

Corticorelin, a synthetic human corticotropin-releasing factor analog, for the treatment of peritumoral brain edema.

Current opinion in molecular therapeutics·2010
Same journal

Mogamulizumab, a humanized mAb against C-C chemokine receptor 4 for the potential treatment of T-cell lymphomas and asthma.

Current opinion in molecular therapeutics·2010
Same journal

Gevokizumab, an anti-IL-1β mAb for the potential treatment of type 1 and 2 diabetes, rheumatoid arthritis and cardiovascular disease.

Current opinion in molecular therapeutics·2010
See all related articles

Area of Science:

  • Oncology
  • Proteomics
  • Biotechnology

Background:

  • Proteomics is crucial for understanding cancer pathophysiology, diagnosis, and drug discovery.
  • Accurate cell extraction from tissue specimens is essential for proteomic analysis.

Purpose of the Study:

  • To highlight the role of proteomics in advancing cancer research.
  • To present laser capture microdissection (LCM) and SELDI technology as key methods in cancer proteomics.

Main Methods:

  • Laser capture microdissection (LCM) for precise cell isolation while preserving tissue morphology.
  • Surface-enhanced laser desorption/ionization (SELDI)-based protein chip technology for analyzing protein expression patterns.

Main Results:

  • Identification of differentially expressed proteins in tumor tissues by comparing protein profiles.

Related Experiment Videos

  • Application of proteomic technologies to study various organ-specific cancers.

    • Conclusions:

    • Proteomics, combined with advanced techniques like LCM and SELDI, significantly contributes to cancer research.
    • Continued refinement of proteomic methods promises improved cancer study and personalized therapeutic strategies.